TG Therapeutics, Inc. (TGTX) Misses Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to TG Therapeutics, Inc. (TGTX) Misses Q1 EPS by 6c

TG Therapeutics, Inc. Announces First Quarter 2014 Financial Results and Business Update

May 12, 2014 4:30 PM EDT

NEW YORK, May 12, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq: TGTX), an innovative clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced its results for the first quarter ended March 31, 2014 and recent company developments.

Financial Results for the First Quarter 2014

At March 31, 2014 the Company had cash, cash equivalents, investment securities, and interest receivable of $54.5 million, as compared to $45.4 million at December 31, 2013.

The consolidated net loss for the first quarter ended March 31,... More